Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
BELLUS Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
BELLUS Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
BELLUS Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
BELLUS Health Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
BELLUS Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
BELLUS Health Inc, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Asclepios Bioresearch To Invest In Bellus Health 11
Licensing Agreements 12
BELLUS Health Enters into Licensing Agreement with NEOMED Institute for BLU-5937 12
Bellus Health Enters into Licensing Agreement with AMO Pharma 13
Bellus Health Enters Into Licensing Agreement With FB Health For Vivimind 14
Bellus Health Enters Into Licensing Agreement With Alzheon For BLU8499 And Its Analogs 15
BELLUS Health Enters Into Licensing Agreement With Integris Pharma For VIVIMIND 16
Bellus Health Enters Into Licensing Agreement With Agahan Ayandeye Pars For Vivimind 17
Advanced Orthomolecular Enters Into Licensing Agreement With BELLUS Health For VIVIMIND 18
Equity Offering 19
BELLUS Health Prices Public Offering of Shares for USD15.7 Million 19
Acquisition 21
NuPharm Italy to Acquire FB Health from BELLUS Health for up to USD2 Million 21
Taro Pharma To Acquire Thallion Pharma for USD2 Million 22
Bellus Health Completes Acquisition Of Thallion Pharma For US$6.3 Million 23
Pharmascience Acquires 10.4% Stake In Bellus Health For US$17.4 Million 24
Advanced Orthomolecular Acquires OVOS Natural Health 26
BELLUS Health Inc – Key Competitors 27
BELLUS Health Inc – Key Employees 28
BELLUS Health Inc – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Financial Announcements 30
Nov 08, 2017: BELLUS Health Reports Financial and Operating Results for the Third Quarter Ended September 30, 2017 30
Aug 09, 2017: BELLUS Health Reports Financial and Operating Results for the Second Quarter Ended June 30, 2017 32
Feb 28, 2017: Bellus Health Reports Financial and Operating Results for the Year Ended December 31, 2016 34
Nov 10, 2016: BELLUS Health reports financial and operating results for the third quarter ended September 30, 2016 36
Aug 09, 2016: BELLUS Health Provides Update on Project Pipeline and Reports Financial and Operating Results for the Second Quarter Ended June 30, 2016 38
May 12, 2016: BELLUS Health reports financial and operating results for the first quarter ended March 31, 2016 40
Feb 24, 2016: Bellus Health Reports Financial and Operating Results for the Year Ended December 31, 2015 42
Corporate Communications 44
Sep 27, 2017: BELLUS Health Appoints Dr. Clarissa Desjardins to its Board of Directors 44
Product News 45
02/24/2016: Bellus Health provides an Update for Shigamab 45
Other Significant Developments 46
Dec 21, 2016: BELLUS Health provides update on pipeline 46
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48
BELLUS Health Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
BELLUS Health Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
BELLUS Health Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
BELLUS Health Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
BELLUS Health Inc, Deals By Therapy Area, 2011 to YTD 2017 9
BELLUS Health Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asclepios Bioresearch To Invest In Bellus Health 11
BELLUS Health Enters into Licensing Agreement with NEOMED Institute for BLU-5937 12
Bellus Health Enters into Licensing Agreement with AMO Pharma 13
Bellus Health Enters Into Licensing Agreement With FB Health For Vivimind 14
Bellus Health Enters Into Licensing Agreement With Alzheon For BLU8499 And Its Analogs 15
BELLUS Health Enters Into Licensing Agreement With Integris Pharma For VIVIMIND 16
Bellus Health Enters Into Licensing Agreement With Agahan Ayandeye Pars For Vivimind 17
Advanced Orthomolecular Enters Into Licensing Agreement With BELLUS Health For VIVIMIND 18
BELLUS Health Prices Public Offering of Shares for USD15.7 Million 19
NuPharm Italy to Acquire FB Health from BELLUS Health for up to USD2 Million 21
Taro Pharma To Acquire Thallion Pharma for USD2 Million 22
Bellus Health Completes Acquisition Of Thallion Pharma For US$6.3 Million 23
Pharmascience Acquires 10.4% Stake In Bellus Health For US$17.4 Million 24
Advanced Orthomolecular Acquires OVOS Natural Health 26
BELLUS Health Inc, Key Competitors 27
BELLUS Health Inc, Key Employees 28
BELLUS Health Inc, Subsidiaries 29